[1]付文洋,马甜甜,曾萍萍,等.鼻鼽的分期论治研究[J].西部中医药,2020,33(03):66-69.[doi:10.12174/j.issn.1004-6852.2020.03.18]
　FU Wenyang,MA Tiantian,ZENG Pingping,et al.Research on Phased Therapy of Allergic Rhinitis[J].Western Journal of Traditional Chinese Medicine,2020,33(03):66-69.[doi:10.12174/j.issn.1004-6852.2020.03.18]
点击复制

鼻鼽的分期论治研究
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
33
期数:
2020年03期
页码:
66-69
栏目:
论坛·博士论坛
出版日期:
2020-03-15

文章信息/Info

Title:
Research on Phased Therapy of Allergic Rhinitis
文章编号:
1004-6852(2020)03-0066-04
作者:
付文洋，马甜甜，曾萍萍，陈玲，丁盼
深圳市中医院/广州中医药大学第四临床医学院，广东 深圳 518000
Author(s):
FU Wenyang, MA Tiantian, ZENG Pingping, CHEN Ling, DING Pan
Shenzhen Traditional Chinese Medicine Hospital / The Forth Clinical Medical School, Guangzhou University of Chinese Medicine, Shenzhen 518000, China
关键词:
鼻鼽; 变应性鼻炎; 分期论治; 辨证论治; 临床疗效
Keywords:
Biqiu;  allergic rhinitis;  phased therapy;  syndrome differentiation and treatment;  clinical effects
分类号:
R287
DOI:
10.12174/j.issn.1004-6852.2020.03.18
摘要:
目的：观察在辨证论治基础上加分期论治对鼻鼽的治疗效果。方法：将肺脾气虚型鼻鼽患者100例随机分为治疗组(辨证论治+分期论治)和对照组(辨证论治)各50例，治疗6周。比较两组患者治疗2周、6周后的效果、主要症状及体征改善情况。结果：1)治疗2周后，两组患者症状、体征与治疗前比较均有改善，差异有统计学意义(P＜0.05)，组间比较差异无统计学意义(P＞0.05)。2）治疗6周后，两组患者症状、体征明显改善，与用药2周比较差异有统计学意义(P＜0.05)；两组组间比较，症状、体征改善程度差异有统计学意义(P＜0.05)。治疗6周后，两组患者流涕、鼻痒、喷嚏症状改善差异有统计学意义(P＜0.05)，且治疗组症状改善优于对照组。结论：在辨证论治的基础上，针对不同时期分期治疗对于改善鼻鼽患者症状效果更好。
Abstract:
Objective: To observe therapeutic effects of phased therapy in the treatment for allergic rhinitis on the foundation of syndrome differentiation and treatment. Methods: All 100 patients with allergic rhinitis of lung and spleen Qi deficiency pattern were randomized into the treatment group(syndrome differentiation and treatment+ phased therapy) and the control group(syndrome differentiation and treatment), 50 cases each group, treated for six weeks. To compare the effects of both goups after treating for two and six weeks, the main symptoms and the improvements of body signs. Results: 1) After treating for two weeks, the symptoms and body signs of both groups improved compared with before treating, and the difference had statistical meaning(P＜0.05), the difference had no statistical meaning between both groups(P＞0.05). 2) After treating for six weeks, the symptoms and body signs of both groups improved notably, and the difference showed statistical meaning compared with after treating for two weeks (P＜0.05); the comparison of the improvements of the symptoms and body signs between both groups showed signficant difference (P＜0.05). After treating for six weeks, the difference showed statistical meaning in the improvements of running nose, rhinocnesmus and sneezing between both groups (P＜0.05), and the improvements of the treatment group was superior to these of the control group. Conclusion: On the foundation of syndrome differen-tiation and treatment, phased therapy for the patients in different periods could improve the symptoms well.

相似文献/References:

[1]张德骞.自拟通窍止鼽汤联合西替利嗪治疗变应性鼻炎的疗效及对TNF-α和IL-4水平的影响[J].西部中医药,2015,28(05):28.
[2]季红健,王东方.变应性鼻炎中医辨证分型与ECP的相关性研究[J].西部中医药,2013,26(05):127.
　JI Hongjian,WANG Dongfang.Correlation Study between ECP and Syndrome Differentiation of Allergic Rhinitis[J].Western Journal of Traditional Chinese Medicine,2013,26(03):127.
[3]卢健敏.温肺止流丹对变应性鼻炎大鼠免疫调节作用机制的研究[J].西部中医药,2013,26(07):26.
　LU Jianmin.Research of WenFei ZhiLiuDan on Immunoregulation Mechanism of Rats with Allergic Rhinitis[J].Western Journal of Traditional Chinese Medicine,2013,26(03):26.
[4]谢强,指导：付文洋.变应性鼻炎中医治疗研究现状[J].西部中医药,2015,28(03):140.
[5]吴小秦,王翔,符国庆,等.温肺健脾方治疗肺脾虚寒型变应性鼻炎91例[J].西部中医药,2021,34(12):84.[doi:10.12174/j.issn.2096-9600.2021.12.22]
　WU Xiaoqin,WANG Xiang,FU Guoqing,et al.Lung-warming Spleen-invigorating Prescription in Treating 91 Patients with Allergic Rhinitis of Lung and Spleen Deficiency-cold Pattern[J].Western Journal of Traditional Chinese Medicine,2021,34(03):84.[doi:10.12174/j.issn.2096-9600.2021.12.22]

备注/Memo

备注/Memo:
收稿日期：2019-08-27作者简介：付文洋(1962—)，男，博士学位，主任医师，教授。研究方向：耳鼻喉科疾病的中医研究。
更新日期/Last Update: 2020-03-15